Session Details
[P2-03]Poster Session 2-03 Cancer Genetics 2
Fri. Dec 19, 2025 5:50 PM - 6:50 PM JST
Fri. Dec 19, 2025 8:50 AM - 9:50 AM UTC
Fri. Dec 19, 2025 8:50 AM - 9:50 AM UTC
Poster Room 1 (301+302, 3F, PACIFICO Yokohama)
[P2-03-1]Sporadic Pleuropulmonary Blastoma in a 1-Year-Old Boy with a Germline Pathogenic Variant in DICER1
Keiko Tanaka1, Hiroaki Hanafusa1,2, Yuki Sawada1, Yoshitaka Asagai1,2, Akihiro Nishimura2, Shiro Kimbara1,3, Ryosuke Bo1,2, Nobuyuki Yamamoto2, Tomonari Kunihisa1,4, Akiharu Kubo1,5, Kandai Nozu1,2 (1.Department of Medical Genetics, Kobe University Hospital, Hyogo, Japan, 2.Department of Pediatrics, Kobe University Graduate School of Medicine, Hyogo, Japan, 3.Department of Oncology and Hematology, Kobe University Graduate School of Medicine, Hyogo, Japan, 4.Department of Breast and Endocrine Surgery, Kobe University Graduate School of Medicine, Hyogo, Japan, 5.Department of Dermatology, Kobe University Graduate School of Medicine, Hyogo, Japan)
[P2-03-2]Preoperative Diagnosis of PPAP in a Client Initially Suspected of FAP: A Case Report
Hiroko Fujita1, Haruka Tada1, Kenji Takashima2, Tetsuji Nobuhisa3, Tomoko Nakayama4, Tetsuya Okazaki1,5, Hideki Yamamoto1,5, Kyohei Kai1, Akira Hirasawa1,5, Kazuo Tamura1,6 (1.Department of Genetic Medicine, Japanese Red Cross Society, Himeji Hospital, Himeji, Japan, 2.Department of Internal Medicine, Japanese Red Cross Society, Himeji Hospital, Himeji, Japan, 3.Department of Surgery, Red Cross Society, Himeji Hospital, Himeji, Japan, 4.Department of Obstetrics and Gynecology, Himeji Hospital, Himeji, Japan, 5.Department of Clinical Genomic Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan, 6.Genetic & Genomic Medical Center, Sakurabashi-Watanabe Future Medical Hospital, Osaka, Japan)
[P2-03-3]Laparoscopic total hysterectomy with bilateral adnexectomy for a client with a pathological germ line variant of RAD51D
Yoshinari Matsumoto1, Tomoko Nakagawa1, Megumi Fudaba1, Ikuji Shimazaki1, Mayu Ueki1, Kazumasa Saigoh2, Atsuko Ikegawa2, Toshiyuki Seto3 (1.Department of Obstetrics and Gynecology, Kishiwada City Hospital, Osaka, Japan, 2.Kindai University Hospital Department of Clinical Genetics, 3.Osaka Metropolitan University Graduate School of Medicine, Department of Medical Genetics)
[P2-03-4]Reevaluation of variants of uncertain significance (VUS) in cancer Comprehensive Genomic Profiling (CGP)
Misako Kaido1,2, Riyo Yoshii3 (1.Department of Clinical Genetics, Sakai City Medical Center, Osaka, Japan, 2.Department of Neurology, Sakai City Medical Center, 3.Department of Nursing, Sakai City Medical Center)
[P2-03-5]Low penetrance variants in exon 1 of RB1: A single institution experience
Chikako Tomozawa1, Mineko Ushiama1,2, Masahiro Goto2, Noriko Tanabe1,3, Tomoko Watanabe1, Manami Matsukawa1, Satoyo Oda1,4, Fumito Yamazaki1, Kokichi Sugano5, Shigenobu Suzuki6, Teruhiko Yoshida1, Makoto Hirata1 (1.Department of Genetic Medicine and Services, National Cancer Center Hospital, 2.Department of Clinical Genomics, National Cancer Center Research Institute, 3.Department of Clinical Genetics, Saitama Medical Center, 4.Department of Clinical Laboratories, National Cancer Center Hospital, 5.Department of Genetic Medicine, Kyoundo Hospital, Sasaki Foundation, 6.Department of Ophthalmic Oncology, National Cancer Center Hospital)
[P2-03-6]A Case of Lynch Syndrome with 12 Associated Tumors
Kohji Tanakaya1, Minami Hatono1,2, Eigo Oka1, Mikoto Nosaka1, Akari Masunaga1, Maho Sato1, Tomohiro Okura1, Toshihiro Ogawa1, Naoto Hori1, Megumi Watanabe1, Takashi Arata1, Koh Katuda1, Hirokazu Sugii2,3, Yuka Sakamoto2,4, Hiromi Sanai2,5, Mami Oshita2,6, Kokichi Sugano7, Hideki Aoki1 (1.Department of Surgery, NHO Iwakuni Clinical Center, Iwakuni, Japan, 2.Department of Clinical Genetics, NHO Iwakuni Clinical Center, Iwakuni, Japan, 3.Department of Obstetrics and Gynecology, NHO Iwakuni Clinical Center, Iwakuni, Japan, 4.Fujito Clinic, Hiroshima, Japan, 5.Department of Obstetrics and Gynecology, Yamaguchi Grand Medical Center, Hofu, Japan, 6.Department of Clinical Genetics, Yamaguchi Grand Medical Center, Hofu, Japan, 7.Department of Clinical Genetics, Kyoundo Hospital, Tokyo, Japan)
[P2-03-7]ERBB2 variants identified by CGP test in a case of recurrent ovarian cancer guided effective treatment two years later
Natsuki Tsuji1, Masako Torishima2, Shigetaka Yagi1, Koichi Terakawa1, Tadayoshi Nagano1, Fumiaki Satou3 (1.Department of Gynecology, Kansai Electric Power Hospital, Osaka, Japan, 2.Department of Genomic Medicine, Kyoto University School of Public Health, Kyoto, Japan, 3.Department of Breast Surgery, Kansai Electric Power Hospital, Osaka, Japan)
[P2-03-8]A case of uterine leiomyosarcoma identified with pathogenic BRCA alterations through genomic profiling analysis
Hiroko Tanaka1, Mayuko Katou1, Kyousou Ishida1, Mikako Miyata2, Mariko Koike2, Yukie Ninomiya2, Tomoko Tsujie1, Naohiro Tomita2 (1.Department of Obstetrics and Gynecology, Toyonaka Municipal Hospital, Osaka, Japan, 2.Department of Cancer Genome Medical Center, Toyonaka Municipal Hospital, Osaka, Japan)
[P2-03-9]A case of Peutz-Jeghers syndrome in which a large deletion of STK11 gene was detected
Hiromi Sugawara1, Sadia Matsutani1, Risa Goto1, Kaori Tane1,2, Miyuki Kawamura1,3, Hideki Sakai1,3, Mitsunori Morita1,3, Takuma Onoe1,3, Koichi Hirokaga1,2, Takashi Shibutani1,4, Kyoko Hamasaki1,4, Keisuke Ogimoto1,4, Shohei Tanabe1,4, Kazuo Tamura1, Koji Matsumoto1,3 (1.Division of Clinical Genetics, Hyogo Cancer Center, 2.Department of Breast Surgery, Hyogo Cancer Center, 3.Department of Medical Oncology, Hyogo Cancer Center, 4.Department of Gynecologic Oncology, Hyogo Cancer Center)
[P2-03-10]Frequency and distribution of large genomic rearrangements in BRCA1 and BRCA2
Sana Yokoi, Ryoko Suzuki, Reiko Ohara, Izumi Miyabe (Division of Cancer Diagnostics, Chiba Cancer Center, Chiba, Japan)
[P2-03-11]What is the penetration rate of hereditary papillary renal cell carcinoma?
Tatsuya Sakashita, Hiroaki Murakami, Mihoko Nagara, Hideo Kaneko (Department of Human Genetics, Gifu Prefectural General Medical Center, Gifu, Japan)
[P2-03-12]Characterization of URST4 as a cancer biomarker and molecular target for breast cancer
Hoa Thi Nguyen1,2, Yataro Daigo1,2,1,2,3, Atsushi Takano1,2,3, Yohei Miyagi4 (1.Department of Medical Oncology and Cancer Center, Shiga University of Medical Science, Otsu, Japan, 2.Center for Advanced Medicine against Cancer, Shiga University of Medical Science, Otsu, Japan, 3.Center for Antibody and Vaccine Therapy, Research Hospital, Institute of Medical Science, The University of Tokyo, Tokyo, Japan, 4.Molecular Pathology and Genetics Division, Kanagawa Cancer Center, Yokohama, Japan)
[P2-03-13]Imaging findings of BRCA-associated breast cancers
Sawaka Yukishige1, Hiroaki Inoue1, Tomohiro Inui1, Mariko Misaki1, Masakazu Goto1, Hiroyuki Morino2, Yukiko Yoshida2, Yoko Miyamoto2, Yoshie Imai3, Soichiro Sasa4, Hiromitsu Takizawa1 (1.Department of Thoracic, Endocrine Surgery and Oncology, Tokushima University Graduate School, 2.Clinical Genomic Center, Tokushima University Hospital, 3.Tokushima University Graduate School of Biomedical Sciences, 4.Tokushima Breast Care Clinic)
[P2-03-14]The contribution of certified specialists in cancer nursing to the decision-making support in cases of MGPT candidates
Keita Hoshino1, Izumi Hanai1, Susumu Miyashita2, Megumi Fujimori3, Shouta Nakagawa3, Rumiko Suzuki3, Jiro Kumagai4 (1.Department of Nursery, Yokohama City Minato Red Cross Hospital, 2.Department of Gynecology and Obstetrics, Yokohama City Minato Red Cross Hospital, 3.Department of Medical Administration, Yokohama City Minato Red Cross Hospital, 4.Department of Pathology, Yokohama City Minato Red Cross Hospital)
[P2-03-15]Current status of hospital-clinic collaboration for hereditary breast cancer
Fuminori Aki1, Ippei Kamidi2, Shinzo Ozaki2, Iyo Nakamura2, Takanori Kawamura3, Tomohiro Okazoe3, Takaaki Masuda4, Misaki Nakaya4, Mari Tashiro5 (1.Ito Breast Surgery Clinic, Kochi, Japan, 2.Hosogi Hospital Surgery, 3.Kochi Seikyou Hospital Surgery, 4.Kochi Medical School Hospital Breast Surgery, 5.Kochi Medical School Hospital Clinical Genetics Department)
[P2-03-16]Assessment of the Clinical Utility of a Dual DNA-RNA Cancer Genomic Panel in the Detection of Gene Fusions
Shingo Kato (Department of Clinical Cancer Genomics, Yokohama City University Hospital, Yokohama, Japan)
